Industry News
U-M researchers find new gene involved in blood-forming stem cells
4/15/2015
Research led by the University of Michigan Life Sciences Institute has identified a gene critical to controlling the body's ability to create blood cells and immune cells from blood-forming stem...
Breath test 'could predict, diagnose stomach cancer'
4/14/2015
Researchers have developed a test that they say could accurately diagnose stomach cancer or predict risk for the disease by analyzing an individual's exhaled breath.
Researchers develop breath test that could predict, diagnose stomach cancer
4/14/2015
Researchers have developed a test that they say could accurately diagnose stomach cancer or predict risk for the disease by analyzing an individual's exhaled breath.
Gold nanoparticles may improve radiation treatment for cancer
4/14/2015
Lab tests show that tethering gold nanoparticles to peptides that seek out cancer cells can intensify the cancer-killing effect of radiation.
The Scottish Medicines Consortium (SMC) has announced that Stivarga® (regorafenib) has been accepted for use within NHS Scotland for the treatment of adult patients with unresectable or...
HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer
4/14/2015
A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts...
Brazilian study suggests adjustments on the treatment of cancer patients with pneumonia
4/14/2015
Cancer patients are more vulnerable to severe pneumonia, but the standard broad-spectrum antibiotic treatment used by physicians worldwide may not be the better choice for this groupCancer...
Aggressive prostate cancer biomarker identified
4/14/2015
Scientists have discovered a new biomarker for prostate cancer that could help clinicians distinguish fast- and slow-growing tumors.
Enzalutamide: Indication of major added benefit for over 75-year-olds
4/14/2015
Men with metastatic prostate cancer receiving enzalutamide live longer and develop symptoms later than those receiving watchful waitingEnzalutamide (trade name: Xtandi) has been approved since...
Potential new biomarker for aggressive prostate cancer identified
4/14/2015
Scientists have discovered a new biomarker for prostate cancer that could help clinicians distinguish fast- and slow-growing tumors.